Future Outlook And Pfizer Inc. Stock Price Performance

In the last trading session, 39.78 million shares of the Pfizer Inc. (NYSE:PFE) were traded, and its beta was 0.60. Most recently the company’s share price was $27.75, and it changed around -$0.03 or -0.11% from the last close, which brings the market valuation of the company to $156.70B. PFE currently trades at a discount to its 52-week high of $42.22, offering almost -52.14% off that amount. The share price’s 52-week low was $25.61, which indicates that the current value has risen by an impressive 7.71% since then. We note from Pfizer Inc.’s average daily trading volume that its 10-day average is 37.79 million shares, with the 3-month average coming to 43.46 million.

Pfizer Inc. stock received a consensus recommendation rating of Hold, based on a mean score of 2.24. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 15 recommended PFE as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Pfizer Inc. is expected to report earnings per share of $0.5 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Pfizer Inc. (NYSE:PFE) trade information

Instantly PFE has showed a red trend with a performance of -0.11% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -3.61% year-to-date, but still up 0.33% over the last five days. On the other hand, Pfizer Inc. (NYSE:PFE) is 2.63% up in the 30-day period. We can see from the shorts that 71.65 million shares have been sold at a short interest cover period of 1.5 day(s).

The consensus price target as assigned by Wall Street analysts is $57.55, which translates to bulls needing to increase their stock price by 51.78% from its current value. Analyst projections state that PFE is forecast to be at a low of $20 and a high of $141.39.

Pfizer Inc. (PFE) estimates and forecasts

Pfizer Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -13.55 percent over the past six months and at a 20.11% annual growth rate that is well above the industry average of 4.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -59.30% in revenue this quarter, and will report a decrease of -37.30% in the next quarter. The year-over-year growth rate is expected to be 2.50%, up from the previous year.

Consensus estimates provided by 13 financial analysts predict the company will bring in an average of $13.15 billion in revenue for the current quarter. 13 analysts expect Pfizer Inc. to make $12.26 billion in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $16.59 billion and $12.73 billion respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -20.80%. Forecasts for the next quarter put sales growth at -3.70%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -27.43%. Pfizer Inc. earnings are expected to increase by 20.34% in 2024, but the outlook is negative -1.20% per year for the next five years.

PFE Dividends

Pfizer Inc.’s next quarterly earnings report is expected to be released around April 30 and May 06. The annual dividend yield of the stock is 5.95 percent and its annual dividend per share was 1.65. It is important to note, however, that the 5.95% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.

Pfizer Inc. (NYSE:PFE)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.05% of Pfizer Inc. shares, and 69.96% of them are in the hands of institutional investors. The stock currently has a share float of 70.00%. Pfizer Inc. stock is held by 3,695 institutions, with Vanguard Group Inc being the largest institutional investor. By Jun 29, 2023, it held 9.00% of the shares, which is about 508.09 million shares worth $18.64 billion.

Blackrock Inc., with 7.88% or 445.15 million shares worth $16.33 billion as of Jun 29, 2023, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 176.05 million shares worth $6.46 billion, making up 3.12% of all outstanding shares. On the other hand, Vanguard 500 Index Fund held roughly 134.41 million shares worth around $4.93 billion, which represents about 2.38% of the total shares outstanding.